1. Home
  2. NLSP vs ICCT Comparison

NLSP vs ICCT Comparison

Compare NLSP & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • ICCT
  • Stock Information
  • Founded
  • NLSP 2015
  • ICCT 1992
  • Country
  • NLSP Switzerland
  • ICCT United States
  • Employees
  • NLSP N/A
  • ICCT N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • ICCT Computer Software: Prepackaged Software
  • Sector
  • NLSP Health Care
  • ICCT Technology
  • Exchange
  • NLSP Nasdaq
  • ICCT Nasdaq
  • Market Cap
  • NLSP 8.2M
  • ICCT 9.1M
  • IPO Year
  • NLSP 2021
  • ICCT N/A
  • Fundamental
  • Price
  • NLSP $0.18
  • ICCT $0.72
  • Analyst Decision
  • NLSP Hold
  • ICCT
  • Analyst Count
  • NLSP 1
  • ICCT 0
  • Target Price
  • NLSP N/A
  • ICCT N/A
  • AVG Volume (30 Days)
  • NLSP 11.0M
  • ICCT 25.7K
  • Earning Date
  • NLSP 07-30-2024
  • ICCT 08-08-2024
  • Dividend Yield
  • NLSP N/A
  • ICCT N/A
  • EPS Growth
  • NLSP N/A
  • ICCT N/A
  • EPS
  • NLSP N/A
  • ICCT N/A
  • Revenue
  • NLSP N/A
  • ICCT $9,034,579.00
  • Revenue This Year
  • NLSP N/A
  • ICCT N/A
  • Revenue Next Year
  • NLSP N/A
  • ICCT N/A
  • P/E Ratio
  • NLSP N/A
  • ICCT N/A
  • Revenue Growth
  • NLSP N/A
  • ICCT 16.06
  • 52 Week Low
  • NLSP $0.11
  • ICCT $0.65
  • 52 Week High
  • NLSP $1.21
  • ICCT $10.60
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 47.81
  • ICCT 31.98
  • Support Level
  • NLSP $0.19
  • ICCT $0.81
  • Resistance Level
  • NLSP $0.24
  • ICCT $0.90
  • Average True Range (ATR)
  • NLSP 0.03
  • ICCT 0.07
  • MACD
  • NLSP -0.00
  • ICCT -0.01
  • Stochastic Oscillator
  • NLSP 10.33
  • ICCT 24.47

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About ICCT iCoreConnect Inc. Common stock

iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

Share on Social Networks: